United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - sodium ferric gluconate complex (unii: cc9149u2qx) (ferric cation - unii:91o4lml611) - ferric cation 12.5 mg in 1 ml - sodium ferric gluconate complex in sucrose injection is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. - known hypersensitivity to sodium ferric gluconate or any of its components. pregnancy category b there are no adequate and well-controlled studies with sodium ferric gluconate complex in sucrose injection in pregnant women. reproduction studies have been performed in mice at doses up to 100 mg/kg/day (300 mg/m2 /day) and in rats at up to 20 mg/kg/day (120 mg/m2 /day). the doses in mice and rats are 4 and 1.5 times the human dose of 125 mg/day (77 mg/m2 /day) on a body surface area basis and have revealed no evidence of harm to the fetus due to sodium ferric gluconate complex in sucrose injection. because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly need

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - ferric carboxymaltose, quantity: 1800 mg (equivalent: iron, qty 500 mg) - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - ferinject is indicated for the treatment of iron deficiency in adults and adolescents aged 14 years and older when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used ? there is a clinical need to deliver iron rapidly,the diagnosis of iron deficiency must be based on laboratory tests.,ferinject is indicated for the treatment of iron deficiency anaemia in children aged 1 to 13 years when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used,the diagnosis of iron deficiency anaemia must be based on laboratory tests.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - ferric carboxymaltose, quantity: 360 mg (equivalent: iron, qty 100 mg) - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - ferinject is indicated for the treatment of iron deficiency in adults and adolescents aged 14 years and older when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used ? there is a clinical need to deliver iron rapidly,the diagnosis of iron deficiency must be based on laboratory tests.,ferinject is indicated for the treatment of iron deficiency anaemia in children aged 1 to 13 years when:,? oral iron preparations are ineffective ? oral iron preparations cannot be used,the diagnosis of iron deficiency anaemia must be based on laboratory tests.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

inca (flight) co pty ltd - cobalt as cobaltous sulfate heptahydrate; copper present as copper sulfate pentahydrate; iron as ferric ammonium citrate, ferrous gluconate, ferr; manganese as manganese sulfate monohydrate - oral solution/suspension - cobalt as cobaltous sulfate heptahydrate mineral-cobalt active 0.2 mg/l; copper present as copper sulfate pentahydrate mineral-copper active 14.7 mg/l; iron as ferric ammonium citrate, ferrous gluconate, ferr mineral-iron active 16.0 g/l; manganese as manganese sulfate monohydrate mineral-manganese active 14.9 mg/l - nutrition & metabolism - dog - greyhound | horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | - iron supplement

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - iron as iron carbonyl and ferric pyrophosphate; vitamin b2 = riboflavin; vitamin b1 nitrate = thiamine nitrate; cobaltous sulfate heptahydrate; glycine; lysine hydrochloride; methionine-dl; copper carbonate; vitamin b12 = cyanocobalamin; vitamin b3 = nicotinamide; vitamin b6 hydrochloride = pyridoxine hydrochloride; vitamin m = folic acid = pga - oral granules, pellets - iron as iron carbonyl and ferric pyrophosphate mineral-iron active 230.0 mg/30g; vitamin b2 = riboflavin vitamin-b2 active 25.0 mg/30g; vitamin b1 nitrate = thiamine nitrate vitamin-b1 active 15.0 mg/30g; cobaltous sulfate heptahydrate mineral-cobalt other 1.0 mg/30g; glycine amino acid-glycine other 100.0 mg/30g; lysine hydrochloride amino acid-lysine other 200.0 mg/30g; methionine-dl amino acid-methionine-dl other 100.0 mg/30g; copper carbonate mineral-copper-salt other 18.0 mg/30g; vitamin b12 = cyanocobalamin vitamin-b12 other 500.0 mg/30g; vitamin b3 = nicotinamide vitamin-b3 other 300.0 mg/30g; vitamin b6 hydrochloride = pyridoxine hydrochloride vitamin-b6 other 15.0 mg/30g; vitamin m = folic acid = pga vitamin-m other 7.5 mg/30g - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - iron deficiency | mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | anaemia | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies

Ireland - English - HPRA (Health Products Regulatory Authority)

vifor france - iron (iii) - solution for injection/infusion - 20 milligram(s)/millilitre - iron trivalent, oral preparations; saccharated iron oxide

Ireland - English - HPRA (Health Products Regulatory Authority)

vifor france - iron (iii) - hydroxide sucrose complex - solution for injection/infusion - 20  milligram(s)/millilitre - iron trivalent, oral preparations; saccharated iron oxide

United States - English - NLM (National Library of Medicine)

rockwell medical, inc - ferric pyrophosphate citrate (unii: uby79oco9g) (ferric cation - unii:91o4lml611) - ferric cation 5.44 mg in 1 ml - triferic is an iron replacement product indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (hdd-ckd). triferic is not intended for use in patients receiving peritoneal dialysis. triferic has not been studied in patients receiving home hemodialysis. none risk summary there are no data with triferic use in pregnant women to inform a drug-associated risk. no teratogenicity was observed in animal reproduction studies with administration of ferric pyrophosphate citrate to pregnant rats and rabbits during organogenesis at doses 96 and 128 times, respectively, the maximum recommended human dose (mrhd) of 27.2 mg per dialysis [see data]. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2%–4% and 15%–20%, respectively. data animal data in a fertility and early embryonic development study in female rats, the maternally toxic ferric py

United States - English - NLM (National Library of Medicine)

nutrexin usa - quinine arsenate (unii: 8c15xfk30p) (quinine arsenate - unii:8c15xfk30p), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), ferrosoferric phosphate (unii: 91gqh8i5f7) (ferrosoferric phosphate - unii:91gqh8i5f7), zinc (unii: j41csq7qds) (zinc - unii:j41csq7qds) - quinine arsenate 12 [hp_x] - provides temporary relief for symptoms such as, fatigue, exhaustion and weakness associated with iron deficiency. provides temporary relief for symptoms such as, fatigue, exhaustion and weakness associated with iron deficiency.

United States - English - NLM (National Library of Medicine)

american regent, inc. - ferric carboxymaltose (unii: 6897gxd6oe) (ferric cation - unii:91o4lml611) - ferric cation 50 mg in 1 ml - injectafer is indicated for the treatment of: •     iron deficiency anemia (ida) in: - adult and pediatric patients 1 year of age and older who have either intolerance or an unsatisfactory response to oral iron. adult and pediatric patients 1 year of age and older who have either intolerance or an unsatisfactory response to oral iron. - adult patients who have non-dialysis dependent chronic kidney disease. adult patients who have non-dialysis dependent chronic kidney disease. •     iron deficiency in adult patients with heart failure and new york heart association class ii/iii to improve exercise capacity. injectafer is contraindicated in patients with a history of hypersensitivity to injectafer or any of its components [see warnings and precautions (5.1) ]. risk summary parenteral iron administration may be associated with hypersensitivity reactions [ see warnings and precautions (5.1)], which may have serious consequences, such as fetal bradycardia (see clinical considerations ). advise pregnant wome